LTA and cancer: Upon introduction of cancer mutations into WT (FBW7ΔDF), the binding of LT to WD40 mutants (R465C, G423V, W425C, A503V, R479Q, R505C and W486*) was diminished (Fig. 1d, Supplementary Table 1).